Form 4: Intuitive Surgical Officer Exercises, Sells Stock

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, exercised stock options and subsequently sold an equal number of common shares under a pre-arranged plan.

Summary

• Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical Inc. (ISRG), engaged in a series of transactions on December 10, 2025.
• Curet acquired 104 shares of Common Stock by exercising non-qualified stock options at a price of $229.39 per share.
• Immediately following the acquisition, Curet disposed of 104 shares of Common Stock at a price of $559.90 per share.
• These transactions were conducted in accordance with a Rule 10b5-1 trading plan, which is set to expire on July 29, 2026.
• Following these transactions, Curet directly owns 0 shares of Common Stock and indirectly owns 353 shares through a Trust.
• Curet continues to hold 1,467 non-qualified stock options directly.
• The options have a vesting schedule where 12.5% vested on the six-month anniversary of February 10, 2023, and 1/48th of the total shares vest in 42 successive equal monthly installments thereafter, contingent on continuous service.

Sentiment

Score: 5

Explanation: The filing details a routine insider transaction under a pre-planned 10b5-1 program, which is generally considered neutral in sentiment. It reflects an executive managing their compensation and liquidity rather than a specific positive or negative signal about the company's immediate prospects.

Positives

• The sale price of $559.90 per share is significantly higher than the exercise price of $229.39, indicating a profitable transaction for the reporting person.
• The transaction was executed under a Rule 10b5-1 trading plan, which demonstrates pre-planning and adherence to insider trading regulations, reducing concerns about opportunistic trading.

Negatives

• The direct beneficial ownership of common stock by the EVP & Chief Medical Officer was reduced to zero following the sale, which might be interpreted as a slight reduction in direct alignment with shareholder interests, although indirect ownership through a trust remains.

Risks

• No specific risks related to the company's operations or financial health are disclosed in this transactional filing.

Future Outlook

This filing is a disclosure of an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or competitive landscape for medical device companies like Intuitive Surgical. It reflects individual executive compensation and liquidity management.

Corporate Governance

Stakeholder Impact

• Shareholders: The transaction is a routine insider sale for liquidity/diversification purposes under a pre-planned program and is unlikely to have a significant direct impact on shareholders. The reduction in direct ownership is minor in the context of the company's overall share structure.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Continued vesting of the remaining 1,467 non-qualified stock options according to the established schedule, contingent on continuous service.

Key Dates

Keywords

ISRG, Intuitive Surgical, Form 4, Insider Transaction, Stock Options, Executive Compensation, Rule 10b5-1 Plan, Myriam Curet